NASDAQ:CBAY
CymaBay Therapeutics Inc
- Stock
Last Close
32.47
21/03 20:00
Market Cap
3.73B
Beta: 0.26
Volume Today
8.35M
Avg: 1.67M
PE Ratio
−23.78
PFCF: −42.19
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -10.07M - | -31.92M 216.86% | -15.53M 51.35% | -26.67M 71.75% | -27.56M 3.32% | -72.55M 163.27% | -102.81M 41.71% | -50.99M 50.41% | -90.00M 76.52% | -106.00M 17.78% | -105.37M 0.60% | |
depreciation and amortization | 55K - | 18K 67.27% | 22K 22.22% | 29K 31.82% | 35K 20.69% | 105K 200% | 572K 444.76% | 632K 10.49% | 688K 8.86% | 710K 3.20% | 681K 4.08% | |
deferred income tax | -90K - | 7.69M 8,645.56% | -10.61M 237.95% | 50K 100.47% | 5.57M 11,048% | 1.75M 68.60% | -3.15M 279.83% | 637K - | -2.73M - | |||
stock based compensation | 892K - | 1.29M 44.84% | 2.49M 92.49% | 2.47M 0.56% | 4.92M 98.95% | 7.01M 42.54% | 10.47M 49.27% | 7.32M 30.03% | 10.00M 36.48% | 9.52M 4.79% | 15.23M 60.03% | |
change in working capital | 701K - | 1.60M 128.82% | 78K 95.14% | 290K 271.79% | -3.04M 1,148.62% | 8.86M 391.32% | -3.91M 144.09% | -1.59M 59.27% | 6.35M 499.18% | -2.34M 136.83% | 5.63M 340.79% | |
accounts receivables | -2K - | -101K 4,950% | 211K 308.91% | -5M - | ||||||||
inventory | 699K - | 304K 56.51% | 938K 208.55% | 1.43M - | ||||||||
accounts payables | 40K - | 1.39M 3,370.00% | -1.08M 177.59% | -109K 89.88% | 412K 477.98% | 662K 60.68% | 530K 19.94% | -2.27M 528.68% | 2.31M 201.63% | -1.44M 162.54% | 2.73M 289.20% | |
other working capital | -36K - | 13K 136.11% | 6K 53.85% | 399K 6,550% | 120K 69.92% | 8.20M 6,730.83% | -4.44M 154.12% | 681K 115.35% | 4.04M 493.54% | -895K 122.14% | 2.90M 424.02% | |
other non cash items | 57K - | 198K 247.37% | 228K 15.15% | 476K 108.77% | 437K 8.19% | -115K 126.32% | 910K 891.30% | -104K 111.43% | 2.90M 2,883.65% | 14.03M 384.73% | 14.03M 0.04% | |
net cash provided by operating activities | -8.46M - | -21.11M 149.63% | -23.32M 10.47% | -23.35M 0.12% | -19.63M 15.93% | -54.94M 179.83% | -97.91M 78.23% | -44.73M 54.32% | -69.43M 55.24% | -84.08M 21.10% | -72.53M 13.74% | |
investments in property plant and equipment | -103K - | -42K - | -27K 35.71% | -529K 1,859.26% | -315K 40.45% | -21K 93.33% | -87K 314.29% | -148K 70.11% | -445K 200.68% | |||
acquisitions net | -199K - | -1.95M 877.39% | -2.24M 15.01% | -104K 95.35% | 637K 712.50% | -874K 237.21% | -7.86M 799.77% | |||||
purchases of investments | -6.93M - | -27.33M 294.26% | -42.79M 56.54% | -22.91M 46.47% | -98.39M 329.52% | -276.38M 180.92% | -290.89M 5.25% | -176.30M 39.39% | -78.08M 55.71% | -174.98M 124.09% | -305.67M 74.69% | |
sales maturities of investments | 44K - | 10.50M 23,761.36% | 31.70M 201.98% | 50.08M 57.94% | 30.88M 38.33% | 222.80M 621.41% | 256.86M 15.29% | 224.28M 12.69% | 126.76M 43.48% | 129.14M 1.88% | 219.55M 70.01% | |
other investing activites | 658K - | 199K - | 1.95M 877.39% | 2.24M 15.01% | 104K 95.35% | -637K 712.50% | 874K 237.21% | 7.86M 799.77% | ||||
net cash used for investing activites | -6.23M - | -16.94M 171.83% | -11.08M 34.57% | 27.13M 344.77% | -67.53M 348.92% | -54.11M 19.87% | -34.35M 36.52% | 47.96M 239.63% | 48.59M 1.32% | -45.98M 194.64% | -86.57M 88.25% | |
debt repayment | -244K - | -4.76M 1,849.18% | -986K 79.27% | -3.14M 218.15% | -6.53M 108.07% | -47.74M - | -25M 47.63% | |||||
common stock issued | 26.51M - | 25.43M 4.09% | 25.38M 0.22% | 100.44M - | 135.52M 34.93% | 107.75M 20.49% | 92K 99.91% | 70.50M 76,529.35% | -459K 100.65% | 345.77M 75,431.59% | ||
common stock repurchased | -3K - | -459K - | ||||||||||
dividends paid | -25M - | |||||||||||
other financing activites | 4.85M - | 51K 98.95% | 9.91M 19,327.45% | 2.42M - | 6.00M 147.73% | 386K 93.56% | 92K 76.17% | 95.69M 103,914.13% | 75.47M 21.14% | |||
net cash used provided by financing activities | 31.36M - | 25.24M 19.54% | 30.53M 20.96% | -986K 103.23% | 99.72M 10,213.49% | 134.99M 35.37% | 108.13M 19.90% | 92K 99.91% | 118.45M 128,655.43% | 24.55M 79.27% | 345.77M 1,308.44% | |
effect of forex changes on cash | -428K - | |||||||||||
net change in cash | 16.68M - | -12.81M 176.85% | -3.88M 69.72% | 2.79M 171.88% | 12.56M 350.30% | 25.94M 106.55% | -24.13M 193.00% | 3.32M 113.78% | 97.61M 2,836.61% | -105.52M 208.10% | 186.24M 276.51% | |
cash at beginning of period | 7.73M - | 24.40M 215.83% | 11.59M 52.52% | 7.71M 33.49% | 10.49M 36.19% | 23.05M 119.67% | 48.99M 112.52% | 24.87M 49.24% | 28.19M 13.37% | 125.81M 346.23% | 20.29M 83.87% | |
cash at end of period | 24.40M - | 11.59M 52.52% | 7.71M 33.49% | 10.49M 36.19% | 23.05M 119.67% | 48.99M 112.52% | 24.87M 49.24% | 28.19M 13.37% | 125.81M 346.23% | 20.29M 83.87% | 206.53M 917.87% | |
operating cash flow | -8.46M - | -21.11M 149.63% | -23.32M 10.47% | -23.35M 0.12% | -19.63M 15.93% | -54.94M 179.83% | -97.91M 78.23% | -44.73M 54.32% | -69.43M 55.24% | -84.08M 21.10% | -72.53M 13.74% | |
capital expenditure | -103K - | -42K - | -27K 35.71% | -529K 1,859.26% | -315K 40.45% | -21K 93.33% | -87K 314.29% | -148K 70.11% | -445K 200.68% | |||
free cash flow | -8.46M - | -21.22M 150.85% | -23.32M 9.93% | -23.39M 0.30% | -19.66M 15.97% | -55.47M 182.14% | -98.23M 77.10% | -44.75M 54.45% | -69.52M 55.36% | -84.23M 21.16% | -72.98M 13.36% |
All numbers in USD (except ratios and percentages)